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Abstract: Background: A new simplified method for the detention of metabolic syndrome (MetS) is
proposed using two variables (anthropometric and minimally invasive). Methods: A study of MetS
prevalence was made on a sample of 361 older people. The anthropometric variables analyzed were:
blood pressure, body mass index, waist circumference (WC), waist–height ratio, body fat percentage,
and waist–hip ratio. A crude and adjusted binary logistic regression was performed, and receiver
operating characteristic curves were obtained for determining the predictive capacity of those variables.
For the new detection method, decision trees were employed using automatic detection by interaction
through Chi-square. Results: The prevalence of the MetS was of 43.7%. The final decision trees uses
WC and basal glucose (BG), whose cutoff values were: for men, WC ≥ 102.5 cm and BG > 98 mg/dL
(sensitivity = 67.1%, specificity = 90.3%, positive predictive value = 85%, validity index = 79.9%);
and for women, WC ≥ 92.5 cm and BG ≥ 97 mg/dL (sensitivity = 65.9%, specificity = 92.7%, positive
predictive value = 87.1%, validity index = 81.3%). In older women the best predictive value of MetS
was a WC of 92.5 cm. Conclusions: It is possible to make a simplified diagnosis of MetS in older
people using the WC and basal capillary glucose, with a high diagnostic accuracy and whose use
could be recommended in the resource-poor health areas. A new cutting point in older women for
the WC should be valued.
Keywords: anthropometry; diagnosis; geriatrics; metabolic syndrome; primary care; rural health
1. Introduction
The metabolic syndrome (MetS) is defined as being a group of risk factors characterized
by central obesity, blood pressure, hyperglycemia, and alterations in the lipid metabolism, i.e.,
hypertriglyceridemia and a diminution in high-density cholesterol (c-HDL) [1]. The MetS is closely
related to type 2 diabetes mellitus, cardiovascular diseases, and other cardiovascular risk factors that
increase morbidity and mortality [2].
Nearly 50% of the elderly population in the USA suffers from MetS [3], while in the Asiatic old
people population (n = 73,547), a prevalence of MetS of 42.6% has been observed [4]. According to
the Spanish ENRICA study [5], the MetS prevalence in the elderly was 42.3%. This percentage is
higher than other age groups, with 11.2% and 30.5% in those between 18 to 44 years and 45 to 64 years,
respectively. For those reasons, the population made up of subjects of 65 years and over is probably
one of the highest clinical interest for the development and application of non-invasive or minimally
Int. J. Environ. Res. Public Health 2020, 17, 5191; doi:10.3390/ijerph17145191 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2020, 17, 5191 2 of 13
invasive methods that permit an early diagnosis of the MetS, especially in places where there is limited
access to resources.
Given that prevalence, the diagnosis of MetS would facilitate a new prediction of cardiovascular
events and total mortality beyond that supplied by other conventional risk factors [6]. Besides, the
determination of abdominal obesity and, more specifically, visceral fat accumulation, has shown itself
to be a critical factor in the pathogenesis of insulin resistance and the onset of the MetS [7,8]. Various
studies [9–11] have demonstrated the real correlation between body and abdominal adiposity with
anthropometric measurements like the body mass index (BMI), the waist circumference (WC), the
waist–hip ratio (WHR), and the waist–height ratio (WHtR).
For all the above, the main objective of this research was to propose a non- or minimally invasive
method for the detection of MetS in the elderly population.
2. Materials and Methods
2.1. Study Design. Population Sample
A prevalence study was carried out during 2019 on 361 older people. The reference population
was formed by individuals of 65 years or over belonging to the Lucena Health Centre (Córdoba,
Spain). Sampling was done randomly according to age and gender. The program EPIDAT version
4.2 (Department of Sanidade, Xunta de Galicia, Galicia, Spain) was used to calculate the sample size.
For an elderly population of approximately 10,000 older people, an expected prevalence of 42.3%
according to the ENRICA study [5], a 95% confidence level and a precision of 5%, the sample size
obtained for the cross-sectional study was of 361 patients.
The inclusion criterion consisted of being 65 years of age or over, but excluding all those individuals
with prolonged hospitalizations, with dementia, and with oncological diseases or palliative treatments.
2.2. Study Variables and Measurements
2.2.1. Result Variable
It was the presence or not of MetS (dichotomic variable). Based on the harmonized definition [12],
i.e., fulfilling three of the following five criteria: blood pressure (BP) ≥ 130/85 mmHg or being under
antihypertensive treatment; triglycerides (TG) ≥ 150 mg/dL or under treatment with fenofibrate or
nicotinic acid; c-HDL < 50 mg/dL for women and < 40 mg/dL for men, or under treatment with
fenofibrate or nicotinic acid; fasting basal glucose ≥ 100 mg/dL, under hypoglycemic treatment or with
a diagnosis of type 2 diabetes mellitus; WC ≥ 88 cm in women and ≥ 102 in men (European population
cut-off points).
2.2.2. Explanatory Variables (Independent Ones)
Personal and lifestyle variables: age, gender, educational level, tobacco use, alcohol consumption,
physical activity performed (moderate–intense exercise > 30 min/day), daily consumption of fruit and
vegetables, polymedication (taking five or more medicines a day during six months or more) [13].
Anthropometric and body composition variables: weight (kg), height (cm), WC (cm), BMI (kg/m2),
waist–height ratio (WHtR): calculated by the ratio between the WC and height in centimeters; waist–hip
ratio (WHR): calculated by the ratio between the WC and the hip circumference in centimeters; the
percentage of body fat (BFP): calculated following the Deurenberg equation; ABSI (A BodyShapeIndex),
BAI (BodyAdiposityIndex), systolic blood pressure (SBP) and diastolic blood pressure (DBP) expressed
in mmHg.
Analysis variables: c-HDL (mg/dL), c-LDL (mg/dL), fasting plasma glucose (mg/dL) and
triglycerides (mg/dL).
2.2.3. Measurement
The data were collected through a medical consultation, where participants met with the principal
investigator. The level of education was classified into no education, primary, secondary and university
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education. Concerning smoking habits, it was aimed to detect active, former, and non-smokers.
The individuals were asked if they did a moderate–intense physical activity of ≥30 min/day and
consumed fruit and vegetables daily, both questions taken from the FINRISK questionnaire [14].
Alcohol intake was also contemplated by following WHO recommendations adapted to Spain [15].
According to the latter, the levels considered to be of risk for persons of over 65 are ≥17 units of
standard drinks per week or over 3 units of standard drink on one occasion.
The anthropometric measurements (height, weight, waist and hip circumference) were taken
following the recommendations in the reference manual for anthropometric standardization [16], and
by trained and experienced staff, in order to minimize the coefficients of variation. The instructions
issued by the European Society of Hypertension [17] to gauge the blood pressure were observed, using
an automatic, calibrated sphygmomanometer (model Omron M3 comfort®, Kyoto, Japan). The BAI
(Body Adiposity Index) [18] was obtained from the equation ((hip perimeter)/((Height)1.5)-18), and for
the ABSI (A Body Shape Index) [19] the calculation was based on the WC, relating it to the BFP and
the height. The analytical values like c-HDL, c-LDL, fasting plasma glucose and triglycerides were
obtained from the last analysis made provided that it had been procured in under one year. If not,
a new serological analysis was requested to determine more recent results.
2.3. Ethical Aspects
The Ethics Committee of the Andalusian Government approved this research project (Ethical
code: File number 272, Reference 3711, Date of approval 02/01/2018). All the study individuals were
informed verbally and in writing on the objectives of the health examination, with an informed consent
being necessary under regulations in force. The study protocol obeyed the Declaration of Helsinki [20]
to perform medical research with humans.
2.4. Statistical Analysis
For the statistical analysis, the programs IBM SPSS Statistics v.25.0 (IBM, Chicago, IL, USA)
and EPIDAT version 4.2 (Department of Sanidade, Xunta de Galicia, Galicia, Spain) have been used.
The continuous and discrete quantitative variables have been represented by the mean and standard
deviation, whereas the qualitative or categorical variables were described by their absolute and relative
frequency. To contrast the goodness of fit to a normal distribution of the data from continuous or
discrete quantitative variables, when n > 50, the Kolmogorov–Smirnov test corrected by Lilliefors
was used, and the graphic representations as histograms, graphs P-P and Q-Q; whereas, if n < 50,
the Shapiro–Wilk test was applied. The homoscedasticity of variances was contrasted with the Levene
test. For the comparison of two independent arithmetical means, the Student-t or Mann–Whitney
U-tests were employed, as was indicated. For the comparison of three or more independent means,
the ANOVA or Kruskal–Wallis tests were applied, according to whether or not it was a parametric test.
A post hoc analysis through the Bonferroni and Tukey tests was made. The comparison of percentages
was carried by the chi-square test, applying Fisher’s exact test when indicated. For contingency tables
with ordinal variables, the Chi-squared of Mantel-Haensel, and the Somers d, the Kendall Tau-b and
Tau-c tests were calculated. A multivariate analysis was performed through a crude and adjusted
binary logistic regression, calculating the goodness of fit of the model from the deviance and the
Hosmer–Lemeshow test. The Wald test was applied as a contrast statistic.
In addition, the crude odds ratio (OR) was calculated with 95% confidence intervals. Receiver
Operating Characteristic curves (ROC) were made, and the Area Under the Curve (AUC) was reckoned
in order to determine what explanatory variables best predicted the presence of MetS. The cut-off points
for each predictive variable were established according to the Youden index (higher joint sensitivity
and specificity). For the diagnostic test study, sensitivity, specificity, predictive values, likelihood ratios,
Youden indices, and diagnostic validity or validity index were taken. Diverse clinical decision trees
were set up (classification), employing for this purpose as a growth method the CHAID (Chi-squared
Automatic Interaction Detection) technique. The level of statistical significance for the division of the
nodes and the fusion of categories was p <0.05; the significance values were corrected by the Bonferroni
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method, and the number of maximum iterations was 100. Statistical significance was fixed for an alpha
error of below 5%, and the confidence intervals were calculated with a 95% certainty.
3. Results
3.1. Prevalence of the Metabolic Syndrome
Of the 361 elderly individuals studied, 192 were women (53.2%). The mean age was of
73.2 ± 6.4 years (CI 95% 72.6–73.9 years). A total of 158 people had the MetS, with a prevalence
of 43.8% (CI 95% 38.6–49.1%). The prevalence of MetS distinguished by gender was 42.7% (CI 95%
35.6–50%) and 45% (CI 95% 37.3–52.8%) for women and men, respectively. None of the personal or
lifestyle variables gave statistically significant results, except for fruit and vegetable consumption, which
was revealed as being a protective factor (OR = 0.44, CI 95% 0.27–0.72, p < 0.01); being polymedicated
behaved as a risk factor (OR = 2.33, CI 95% 1.43–3.78, p < 0.01). Regarding the anthropometric variables,
most of them were associated significantly with MetS except DBP.
Table 1 shows characteristics about the presence of MetS, or not, and a logistic regression with a
crude OR.
Table 1. Characteristics and logistic regression of the elderly population (n = 361) with or without MetS.







Age (years) 73.2 (6.4) 73.2 (6.0) 73.3 (6.7) 1.00 (0.97–1.03) NS
Gender
Women 192 (53.2%) 82 (42.7%) 110 (57.3%) 1 -
Men 169 (46.8%) 76 (45.0%) 93 (55.0%) 1.10 (0.72–1.66) NS
Education level
N/P 303 (83.9%) 129 (42.6%) 174 (57.4%) 1 -
S/U 58 (16.1%) 29 (50%) 29 (50%) 1.35 (0.77–2.37) NS
Smoking
Non-smoker 257 (71.2%) 108 (42%) 149 (58%) 1
Quitter 78 (21.6%) 36 (46.2%) 42 (53.8%) 1.18 (0.71–1.97) NS
Smoker 26 (7.2%) 14 (53.8%) 12 (46.2%) 1.61 (0.72–3.62) NS
Risk drinker
No 286 (79.2%) 124 (43.4%) 162 (56.6%) 1 -
Yes 75 (20.8%) 34 (45.3%) 41 (54.7%) 1.08 (0.65–1.81) NS
Physical activity
No 235 (65.1%) 110 (46.8%) 125 (53.2%) 1 -
Yes 126 (34.9%) 48 (38.1%) 78 (61.9%) 0.70 (0.45–1.09) NS
Fruit/vegetables
consumption
No 269 (74.5%) 104 (38.7%) 165 (61.3%) 1 -
Yes 92 (25.5%) 54 (58.7%) 38 (41.3%) 0.44 (0.27–0.72) <0.01
Polymedicated
No 270 (74.8%) 104 (38.5%) 166 (61.5%) 1 -
Yes 91 (25.2%) 54 (59.3%) 37 (40.7%) 2.33 (1.43–3.78) <0.01
Anthropometric
variables
WC (cm) 100.41 (12.2) 105.9 (10.5) 96.1 (11.6) 1.08 (1.06–1.11) <0.001
HC (cm) 106.72 (9.50) 109.41 (9.60) 104.63 (8.92) 1.06 (1.03–1.08) <0.001
WHR * 0.94 (0.09) 0.97 (0.08) 0.92 (0.09) 1.18 (1.10–1.26) <0.001
WHtR * 0.64 (0.07) 0.67 (0.06) 0.61 (0.06) 1.29 (1.83–1.41) <0.001
BFP (%) 35.6 (5.3) 37.5 (5.4) 34.2 (4.8) 1.13 (1.08–1.19 <0.001
ABSI * 0.13 (0.01) 0.14 (0.01) 0.13 (0.01) 0.35 (0.21–0.60) <0.001
BAI 36.15 (6.71) 37.10 (6.83) 35.40 (6.53) 1.04 (1.01–1.07) <0.05
BMI (kg/m2) 29.2 (4.5) 30.7 (4.6) 28.0 (4.0) 1.16 (1.10–1.23) <0.001
SBP (mmHg) 140.2 (19.9) 146.8 (18.4) 135.1 (19.53) 1.03 (1.02–1.05) <0.001
DBP (mmHg) 77.5 (10.6) 78.5 (11.1) 76.7 (10.1) 1.02 (1–1.04) NS
Biochemicalvariables
BG (mg/dL) 105.4 (31.3) 118.4 (38.5) 95.3 (19.0) 1.04 (1.03–1.05) <0.001
cHDL (mg/dL) 55.3 (14.7) 49.5 (12.9) 59.9 (14.4) 0.94 (0.92–0.96) <0.001
cLDL (mg/dL) 121.6 (35.7) 115.0 (37.1) 126.7 (33.7) 0.99 (0.98–0.997) <0.01
TG (mg/dL) 123.9 (56.9) 152.8 (67.3) 101.5 (33.1) 1.02 (1.02–1.03) <0.001
MetS: metabolic syndrome; CI: confidence interval; NS: not significant; N/P: None or Primary Studies; S/U: Secondary
or University studies; WC: waist circumference; HC: hip circumference; WHR: waist–hip ratio; WHtR: waist–height
ratio; BFP: body fat percentage; ABSI: A Body Shape Index; BAI: Body Adiposity Index; BMI: body mass index; SBP:
systolic blood pressure; DBP: diastolic blood pressure; BG: basal glucose; cHDL: cholesterol high-density lipoprotein;
cLDL: cholesterol low-density lipoprotein TG: triglycerides. * WHR, WHtR, and ABSI: transformed as the square
root of the Napierian Logarithm, only for logistic regression analysis.
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3.2. Anthropometric Variables and Predictive Analyses of the MetS
For predictive analysis of anthropometric variables, only those with OR crude with statistical
significance were analyzed. Furthermore, only the variables with the best values of AUC (BMI, WC,
WtHR and BFP) were presented. Figure 1A shows the different ROC curves for the anthropometric
and analytical variables with the best AUC, separated according to sex in Figure 1B,C.
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Table 2 shows the AUC, cutoff points, sensitivity (S), specificity (SP) and Youden index (J) for
the most significant anthropometric and analytical variables. ithin the analytical variables, basal
glucose (AUC = 0.77; S = 74.1%, SP = 74.4%, J = 0.48) and triglycerides (AUC = 0.77; S = 59.5%,
SP = 87.7%, J = 0.47) stand out. As for the anthropometric variables, the WHtR (AUC = 0.74; S = 79.1%,
SP = 61.6%, J = 0.41) and the WC (AUC = 0.73; S = 65.2%, SP = 71.9%, J = 0.37) exhibited a higher
predictive capacity.
ith regard to gender, in the case of men, the triglycerides (AUC = 0.77; S = 53.9%, SP = 95.7%,
J = 0.50), the WC (AUC = 0.75; S = 86.8%, SP = 61.3%, J = 0.48) and the WHtR (AUC = 0.75; S = 77.6%,
SP = 69.9%, J = 0.47) were prominent. However, for women, the best values were obtained for basal
glucose (AUC = 0.80; S = 72%, SP = 83.6%, J = 0.56), triglycerides (AUC = 0.77; S = 59.8%, SP = 87.3%,
J = 0.47) and the WC (AUC = 0.77; S = 82.9%, SP = 62.7%, J = 0.46).
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Table 2. Diagnostic accuracy of predictive variables for MetS in the elderly population (n = 158). Total
sample and according to gender.
Gender Variable AUC p-Value 95% CI Cut-OffPoint S (%) SP (%) J
Total
BG (mg/dL) 0.77 <0.001 0.72–0.82 98.5 74.1 74.4 0.48
TG (mg/dL) 0.77 <0.001 0.71–0.82 137 59.5 87.7 0.47
WHtR 0.74 <0.001 0.69–0.79 0.62 79.1 61.6 0.41
WC (cm) 0.73 <0.001 0.68–0.78 102.1 65.2 71.9 0.37
BMI (kg/m2) 0.67 <0.001 0.62–0.73 27.5 77.8 50.7 0.29
SBP (mmHg) 0.67 <0.001 0.62–0.73 129.5 89.2 37.9 0.27
Body fat (%) 0.67 <0.001 0.62–0.73 33.6 79.7 51.2 0.31
Men
BG (mg/dL) 0.73 <0.001 0.66–0.81 98.5 78.9 61.3 0.40
TG (mg/dL) 0.77 <0.001 0.69–84.5 145.5 53.9 95.7 0.50
WHtR 0.75 <0.001 0.68–0.83 0.64 77.6 69.9 0.47
WC (cm) 0.75 <0.001 0.68–0.83 102.75 86.8 61.3 0.48
BMI (kg/m2) 0.72 <0.001 0.64–0.80 27.5 84.2 55.9 0.40
SBP (mmHg) 0.71 <0.001 0.63–0.78 141.5 63.2 68.8 0.32
Body fat (%) 0.71 <0.001 0.63–0.79 33 88.2 53.8 0.42
Women
BG (mg/dL) 0.80 <0.001 0.74–0.87 97.5 72 83.6 0.56
TG (mg/dL) 0.77 <0.001 0.69–0.83 138.5 59.8 87.3 0.47
WHtR 0.73 <0.001 0.67–0.81 0.62 73.2 65.5 0.39
WC (cm) 0.77 <0.001 0.70–0.83 93.25 82.9 62.7 0.46
BMI (kg/m2) 0.64 <0.001 0.56–0.72 28.5 62.2 57.3 0.19
SBP (mmHg) 0.65 <0.001 0.57–0.72 129.5 90.2 62.7 0.27
Body fat (%) 0.64 <0.001 0.56–0.72 33.7 75.6 49.1 0.25
ROC: receiver operator characteristic; AUC: Area under the curve; S: sensibility, SP: specificity, J: Youden index,
MetS: metabolic syndrome, BG: basal glucose; TG: triglycerides; WHtR: waist–height ratio, WC: waist circumference,
BMI: body mass index SBP: systolic blood pressure.
3.3. Design of Decision Tree to Detect MetS Based on Non-Invasive or Minimally Invasive Tests
The following step was to develop different decision trees for the detection of MetS by taking the
predictive variables that showed the most significant diagnostic accuracy. Different decision trees were
elaborated, placed for each of the independent variables as the first entry. Of all the trees obtained,
those showing the best predictive capacity satisfied most of the following criteria: no independent
variable placed first, a minimum number of 60 individuals in the parent node, and a minimum number
of 30 subjects in the child node.
Figure 2 shows the decision trees (classification algorithm) with the best predictive capacity.
The best model for the overall sample Figure 2A was that formed by the WHtR and the basal glucose
(S = 61.4%, SP = 89.2%, PPV = 81.5, validity index or VI = 77%); whereas the combination of WC
and basal glucose offered a worse model in the overall sample, Figure 2B (S = 50.6%, SP = 93.1%,
PPV = 85.1%, VI 74.5%).
Separating by gender Figure 3, the decision trees with the highest predictive capacity were
obtained with the WC and the basal glucose. The one with the highest predictive capacity in men,
Figure 3A, employed the WC cut-off points ≥ 102.5 cm and basal glucose > 98 mg/dL (S = 67.1%,
SP = 90.3%, PPV = 85%, VI = 79.9%). Regarding women, Figure 3B, the cut-off points were established
at WC ≥ 92.5 cm and in basal glucose at ≥ 97 mg/dL (S = 65.9%, SP = 92.7%, PPV = 87.1%, VI = 81.3%).
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Figure 3. Diagnostic decision trees for detection of MetS in elderly women (n = 82) and men (n = 76).
(A) Model that uses WC and basal glucose in lder men; (B) Model that uses WC and basal glucose in
older women. MetS: met bolic yndrome; WtHR: waist–height ratio, WC: waist circumference, BG:
basal glucose. S: sensibility; SP: specifi ity; PPV: positive predictive value; VI: validity index.
Table 3 shows the principal predictive indicators for the MetS diagnostic models (prevalence,
sensitivity, specificity, positive predictive value, negative predictive value, positive and negative
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likelihood ratio, validity index, and Youden index) with their corresponding 95% confidence intervals.
As a final decision tree, a specific model for men and women has been selected (J = 0.59), respectively,
using the WC and the basal glucose, since the Youden index in both cases improves the diagnostic
accuracy by 9% compared to the global tree.
Table 3. Leading predictive indicators for the MetS diagnosis models in the elderly population.
Indicator Total Percentage (IC95%) Men Percentage(IC 95%)
Women Percentage
(IC 95%)
WHtR/BG WC/BG WC/BG WC/BG
Prevalence 43.8% (38.6–49.1) 45% (37.3–52.8) 42.7% (35.6–50)
Sensibility 61.4% (53.6–68.6) 50.6% (42.9–58.3) 67.1% (55.9–76.6) 65.9% (55.1–75.2)
Specificity 89.2% (84.1–92.7) 93.1% (88.8–95-8) 90.3% (82.6–94.8) 92.7% (86.3–96.3)
PPV 81.5% (73.6–87.5) 85.1% (76.5–90.9) 85% (73.9–91.9) 87.1% (76.6–93.3)
NPV 74.8% (69–79.8) 70.8% (65.1–75.9) 77.1% (68.3–84) 78.5% (70.6–84.7)
LH+ 5.66 (3.75–8.57) 7.34 (4.33–12.45) 6.93 (3.65–13.16) 9.05 (4.56–17.97)
LH- 0.43 (0.35–0.53) 0.53 (0.45–0.63) 0.36 (0.26–051) 0.37 (0.27–0.50)
VI 77% (72.4–81.1) 74.5% (69.8–78.7) 79.9% (73.2–85.2) 81.3% (75.1–86.1)
J 0.51 (0.42–0.59) 0.44 (0.35–052) 0.57 (0.45–0.7) 0.59 (0.47–0.7)
PPV: positive predictive value; NPV: negative predictive value; LH+: likelihood ratio positive; LH-: likelihood
ratio negative. VI: validity Index; J: Youden’s Index; WHtR: waist–height ratio, WC: waist circumference, BG:
basal glucose.
4. Discussion
This work proposes a new minimally invasive method for the detection of MetS in the elderly
population, based on a metabolic, partly anthropometric, phenotype, and defined by the WC and
basal glucose.
The general prevalence of the MetS in our study was 43.8%, which was similar to the data found
in other MetS prevalence studies. In the ENRICA study (n = 2050 older people), MetS prevalence in
the over 65s was estimated at around 42.3% [5]. In Brazil, different prevalence in older people were
seen according to their age groups: 60–69 years (48.6%), 70–79 (41.6%), and 80 or over (45.2%) [21].
When differentiating between sexes, a prevalence of MetS is found of 45% in men and 42% in women,
which differs from most studies in which the prevalences are significantly higher [3,22–24]. However,
in a Mexican study [25] (n = 516), a higher prevalence in men, 75.7%, was shown than in women
(70.4%).
The anthropometric variables that displayed the highest predictive capacity (larger AUC) were
the WHtR (0.74) and the WC (0.73). Concerning gender, in the older men, their WHtR and WC stood
out with an AUC of 0.75 for both. In the women, the best anthropometric variable was the WC, with an
AUC of 0.77. All these results agreed with the scientific literature, in whose analyses of cardiovascular
risk and metabolic syndrome in older people, both the WHtR and the WC, stood out over the rest in as
far as their predictive power was concerned [26–28].
Regarding the analytical variables, basal glucose and the triglycerides presented an AUC of 0.77.
Basal glucose achieved a greater sensitivity and specificity together (J = 0.48). Separately, in men, the
triglycerides (AUC = 0.77) and basal glucose (AUC = 0.76) were notable, whereas in women it was
basal glucose (AUC = 0.80) and the triglycerides (AUC = 0.76), with the best Youden Index being
for basal glucose (J = 0.57). Thus, it was corroborated that the level of blood glucose is an analytical
variable related to the MetS, due to the increase in the risk and mortality of cardiovascular disease [29],
especially in older women [30]. However, in other works, the WC, blood pressure, and basal glucose
were the variables that presented the highest prevalence of MetS in the elderly population [31].
Int. J. Environ. Res. Public Health 2020, 17, 5191 10 of 13
After performing various tests for constructing the clinical decision tree by the CHAID method,
up to four decision trees were selected. Finally, the best option for each sex was considered to be; the
tree configured with the WC and basal glucose with validity indexes of 79.9% and 81.3%, for men and
women, respectively. It can likewise be regarded as being a minimally invasive method since the basal
glucose can be obtained from the basal capillary glucose. This test has already been validated as a
screening method for the detection of type 2 diabetes or altered basal glucose [32].
The CHAID method has already proved to be a useful tool in the diagnosis of MetS [33]. In other
works, some non- or minimally invasive methods have been proposed for the MetS. It should be noted
that in the revised literature for MetS, we have not found publications with clinical decision trees
constructed by the CHAID method that have reported negative evaluations or results. In Miller et
al., a decision tree elaborated with CHAID was also used to detect MetS in a young adult population,
simultaneously including anthropometry and analytical variables like WC and glucose, among
others [34]. In a recent study, WHtR was reported as being a screening method for determining MetS
in an elderly Japanese population [35]. The NIM-MetS method suggested by Romero-Sadaña, M et
al. [36] is also worth noting; this method is based on the measurement of WHtR and blood pressure in
a working population. In DeKroon et al.’s study, the decision tree considered three anthropometric
variables (BMI, WC, and blood pressure) to identify the MetS in young adults. The risk of having
the MetS was heavier when the WC and the blood pressure were high [37]. Finally, DY. Hsiung et al.
recommended non-invasive variables (blood pressure, the BMI, heart rate) as risk predictors of MetS at
its earliest stage [38].
The cut-off points for the anthropometric variables are specific for each population group (ethnicity,
age, and gender) [3,23,24,39]. Although the WC cut-off point for men (102.5 cm) was similar to that
used in the harmonized definition, in the WC/basal glucose model for older women, a different point
from that established for the WC (92.5 cm) is observed. In a study in Brazil [40], with 113 older women,
a cut-off MetS predictor point of 92 cm for WC was observed, whereas Akbulut et al. (n = 137) [41]
found another one of 95.9 cm. This fact demonstrates the need, in our opinion, to reconsider whether
the cut-off point proposed by the harmonized definition, IDF, and ATP-III of WC, should be adapted
for older women.
The model proposed here, both for men and women, are useful for assessing whether or not to
take a blood test. It is an especially important aspect in situations with lower accessibility to health
resources like rural populations that are highly dispersed geographically. If, for example, we have an
older woman with a WC of 93 cm and a basal glucose of 99 mg/dL, she would be highly likely to have
the MetS (VPP = 87.1%), so that it would be appropriate to perform a confirmatory analysis. If, on the
contrary, we have the case of one with a WC of 91 cm and a basal glucose of 96 mg/dL, she would have
a scant probability of suffering from the MetS (VPN = 78.5%), so that no analysis would be necessary.
The high PPV’s of the models cited agree with a study of hospitalized older patients, in which WC
was proposed as an anthropometric measurement for improving the PPV for the MetS diagnosis [42].
Besides, both models presented a higher specificity (90.3% men, 92.7% men) and a lower sensitivity
(67.1% men, 65.9% women); whereas the positive predictive values of the models were PPV: 85%
and NPV: 77.1%, for men; and PPV: 87.1% and NPV: 78.5%, for women. With all these data, we can
highlight that a test with a high specificity would be beneficial for the diagnosis of this cluster of
cardiovascular risk factors, which have a high prevalence, such as the metabolic syndrome in the
elderly. If the test is negative, further invasive testing can be avoided, saving costs and unnecessary
discomfort for our patients.
Limitations
The CHAID methodology used for setting up the decision tree recommends large sample sizes in
order to optimize their statistical significance. The sample taken in this study, separated per sexes,
was for men (n = 198) and women (n = 169). The criteria for forming parent and child nodes were
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moderate ones (60 and 30, respectively). It would, therefore, be helpful to employ larger samples for
future studies to obtain a higher reliability.
It would also be of interest to make a study to validate the simplified method proposed using
the same reference test (harmonized definition of the MetS) in another sample. It would permit us
to find out the diagnostic validity indicators of the models proposed according to gender, in another
population, and in a different clinical context from the one that was used to develop this present
predictive model.
5. Conclusions
The simplified MetS diagnostic method in older people proposed using the measurement of the
WC and taking basal capillary glucose is seen to be a highly accurate one for men (VI = 79.9%) and
women (VI = 81.3%).
It is a minimally invasive diagnostic method with numerous advantages to others. First, it only
uses two variables (WC and basal capillary glucose) that are easily accessible in any healthcare context
(i.e., primary and hospital attention, occupational health, nursing homes), which reduces the frequency
of using blood tests and only in those cases requiring a confirmation. Finally, it is an economical,
versatile method and is easily interpreted through the algorithms proposed.
Incidentally, it was observed that a WC starting from 92.5 cm performs better as a MetS predictor
cut-off point in older women than that proposed in the IDF definitions, harmonized and ATP-III.
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